Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Clinical trial NCT02418754 · TERMINATED
Trial details
- NCT number
- NCT02418754
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-05
- Primary completion
- 2016-08-17
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.